Skip to main content

Table 1 Baseline characteristics according to the 1-year all-cause mortality

From: In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure

 

Event (−)

(n = 2,034)

Event (+)

(n = 583)

Total

(n = 2,617)

P value

Age, years

71 (59–78)

76 (70–82)

72 (61–79)

 < 0.001

Male sex, n (%)

1097 (54)

282 (48)

1379 (53)

0.02

BMI, kg/m2

23 (21–26)

22 (20–25)

23 (21–25)

 < 0.001

Past medical history, n (%)

Hypertension

1161 (57)

396 (68)

1557 (60)

 < 0.001

Diabetes

840 (41)

270 (46)

1110 (42)

0.035

CKD

272 (13)

153 (26)

425 (16)

 < 0.001

Previous HF admission

633 (31)

244 (42)

877 (34)

 < 0.001

Ischemic heart disease

544 (2.7)

193 (33)

737 (28)

0.003

Atrial fibrillation

689 (34)

217 (37)

906 (35)

0.148

ICD

20 (1)

8 (1)

28 (1)

0.564

CRT

14 (1)

6 (1)

20 (1)

0.573

Physical examination on admission

SBP, mmHg

130 (110–151)

126 (106–146)

130 (110–150)

0.01

DBP, mmHg

77 (66–90)

76 (61–88)

77 (65–89)

0.008

Pulse rate, beats/min

92 (76–110)

91 (77–110)

91 (76–110)

0.88

NYHA III/IV, n (%)

1,760 (87)

530 (91)

2,290 (88)

0.006

Echocardiographic parameters

LVEF, % (n = 2542)

37 (27–52)

36 (26–52)

37 (27–52)

0.302

LVEF < 40%, n (%)

1,071 (54)

312 (56)

1,383 (54)

0.357

Laboratory parameters

Serum creatinine, mg/dL

1.1 (0.8–1.5)

1.3 (0.9–2.0)

1.1 (0.8–1.6)

 < 0.001

eGFR, mL/min/1.73m2

65 (43–87)

48 (29–70)

61 (39–84)

 < 0.001

Serum sodium, mEq/L

138 (135–141)

137 (133–140)

138 (135–141)

 < 0.001

Hemoglobin, g/dL

12.5 ± 2.3

11.5 ± 2.1

12.2 ± 2.3

 < 0.001

BNP, pg/mL (n = 1224)

883 (457–1,642)

1,303 (673–2,667)

963 (500–1859)

 < 0.001

NT-proBNP, pg/mL (n = 1263)

4827 (2063–10,954)

9,559 (4,026–25,515)

5313 (2373–13,200)

 < 0.001

Treatments during index hospitalization, n (%)

Inotropic use

1820 (90)

541 (93)

2361 (90)

0.022

Mechanical ventilation

451 (22)

105 (18)

556 (21)

0.035

RRT

131 (6)

78 (13)

209 (8)

 < 0.001

CRRT

55 (42)

37 (47)

92 (44)

0.533

MCSD

138 (7)

27 (5)

165 (6)

0.074

IABP

94 (5)

24 (4)

118 (5)

0.686

ECMO

70 (3)

5 (1)

75 (3)

0.002

Hospital stay, days

10 (6–18)

12 (7–22)

10 (7–19)

 < 0.001

Medications at discharge, n (%)

ACEi/ARBs

1371 (67)

325 (56)

1696 (65)

 < 0.001

Loop diuretics

1418 (70)

412 (71)

1830 (70)

0.695

Beta-blockers

1009 (50)

223 (38)

1232 (47)

 < 0.001

MRAs

947 (47)

243 (42)

1190 (46)

0.042

  1. Values are median (interquartile range), number (%), or mean ± standard deviation
  2. ACEi/ARB, angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker; BNP, brain natriuretic peptide; CRRT, continuous renal replacement therapy; CRT, cardiac resynchronization therapy; DBP, diastolic blood pressure; ECMO, extracorporeal membrane oxygenation therapy; eGFR, estimated glomerular filtration rate; IABP, intra-aortic balloon pump; ICD, implantable cardioverter-defibrillator; LVEF, left ventricular ejection fraction; MCSD, mechanical circulatory support devices; MRA, mineralocorticoid receptor antagonist; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; RRT, renal replacement therapy; SBP, systolic blood pressure